Delivery Order SPE2DB22D1202-SPE2DB25FUSQ4

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.45, is a Delivery Order for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract has a firm fixed price and an ultimate completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Trileptal 300 mg/5 ml suspension. The $2,368.56 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $1,013.61, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, a pharmaceutical product used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRILEPTAL 300 MG/5 ML SUSP 250ML. The Delivery Order, valued at $7,223.90, has a firm fixed-price structure and an ultimate completion date of October 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $4,176.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and is priced on a firm fixed-price basis. The contract provides for the delivery of Trileptal, a 300 mg/5 ml suspension medication used to treat epilepsy, with a completion date of May 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corporation is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,143.92, has a completion date of September 10, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT2X1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $1,785.44 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FTW78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,396.68 Firm Fixed Price Delivery Order contract is for the supply of Trileptal 300 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $9,385.28 and covers the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSQ4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.25 Firm Fixed Price Delivery Order is for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, with no major subcontractors listed. This award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/14/25, 10:29 AM